Browsing by Author "De Wit, Cor (7005808759)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Cardiovascular disease and COVID-19: A consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)(2021) ;Cenko, Edina (55651505300) ;Badimon, Lina (7102141956) ;Bugiardini, Raffaele (26541113500) ;Claeys, Marc J (7102514922) ;De Luca, Giuseppe (55586620900) ;De Wit, Cor (7005808759) ;Derumeaux, Geneviève (55699348000) ;Dorobantu, Maria (6604055561) ;Duncker, Dirk J (7005277014) ;Eringa, Etto C (6507199239) ;Gorog, Diana A (7003699023) ;Hassager, Christian (7005846737) ;Heinzel, Frank R (7005851989) ;Huber, Kurt (35376715600) ;Manfrini, Olivia (6505860414) ;Milicic, Davor (56503365500) ;Oikonomou, Evangelos (36717891800) ;Padro, Teresa (6701424923) ;Trifunovic-Zamaklar, Danijela (9241771000) ;Vasiljevic-Pokrajcic, Zorana (6602641182) ;Vavlukis, Marija (14038383200) ;Vilahur, Gemma (57205093142)Tousoulis, Dimitris (35399054300)The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19). Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or indirectly related to the intense systemic inflammatory and immune responses are characteristic features of severe COVID-19. Pre-existing cardiovascular disease and viral load are linked to myocardial injury and worse outcomes. The vascular response to cytokine production and the interaction between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and angiotensin-converting enzyme 2 receptor may lead to a significant reduction in cardiac contractility and subsequent myocardial dysfunction. In addition, a considerable proportion of patients who have been infected with SARS-CoV-2 do not fully recover and continue to experience a large number of symptoms and post-acute complications in the absence of a detectable viral infection. This conditions often referred to as 'post-acute COVID-19' may have multiple causes. Viral reservoirs or lingering fragments of viral RNA or proteins contribute to the condition. Systemic inflammatory response to COVID-19 has the potential to increase myocardial fibrosis which in turn may impair cardiac remodelling. Here, we summarize the current knowledge of cardiovascular injury and post-acute sequelae of COVID-19. As the pandemic continues and new variants emerge, we can advance our knowledge of the underlying mechanisms only by integrating our understanding of the pathophysiology with the corresponding clinical findings. Identification of new biomarkers of cardiovascular complications, and development of effective treatments for COVID-19 infection are of crucial importance. © 2021 Published on behalf of the European Society of Cardiology. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation(2020) ;Vaccarino, Viola (7007183729) ;Badimon, Lina (7102141956) ;Bremner, J. Douglas (57203217226) ;Cenko, Edina (55651505300) ;Cubedo, Judit (38861393900) ;Dorobantu, Maria (6604055561) ;Duncker, Dirk J. (7005277014) ;Koller, Akos (7102499922) ;Manfrini, Olivia (6505860414) ;Milicic, Davor (56503365500) ;Padro, Teresa (6701424923) ;Pries, Axel R. (7004297733) ;Quyyumi, Arshed A. (57216326695) ;Tousoulis, Dimitris (35399054300) ;Trifunovic, Danijela (9241771000) ;Vasiljevic, Zorana (6602641182) ;De Wit, Cor (7005808759) ;Bugiardini, Raffaele (26541113500) ;Lancellotti, Patrizio (7003380556)Carneiro, António Vaz (57195357951)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'(2020) ;Padro, Teresa (6701424923) ;Manfrini, Olivia (6505860414) ;Bugiardini, Raffaele (26541113500) ;Canty, John (7005042319) ;Cenko, Edina (55651505300) ;De Luca, Giuseppe (55586620900) ;Duncker, Dirk J. (7005277014) ;Eringa, Etto C. (6507199239) ;Koller, Akos (7102499922) ;Tousoulis, Dimitris (35399054300) ;Trifunovic, Danijela (9241771000) ;Vavlukis, Marija (14038383200) ;De Wit, Cor (7005808759)Badimon, Lina (7102141956)Although myocardial ischaemia usually manifests as a consequence of atherosclerosis-dependent obstructive epicardial coronary artery disease, a significant percentage of patients suffer ischaemic events in the absence of epicardial coronary artery obstruction. Experimental and clinical evidence highlight the abnormalities of the coronary microcirculation as a main cause of myocardial ischaemia in patients with 'normal or near normal' coronary arteries on angiography. Coronary microvascular disturbances have been associated with early stages of atherosclerosis even prior to any angiographic evidence of epicardial coronary stenosis, as well as to other cardiac pathologies such as myocardial hypertrophy and heart failure. The main objectives of the manuscript are (i) to provide updated evidence in our current understanding of the pathophysiological consequences of microvascular dysfunction in the heart; (ii) to report on the current knowledge on the relevance of cardiovascular risk factors and comorbid conditions for microcirculatory dysfunction; and (iii) to evidence the relevance of the clinical consequences of microvascular dysfunction. Highlighting the clinical importance of coronary microvascular dysfunction will open the field for research and the development of novel strategies for intervention will encourage early detection of subclinical disease and will help in the stratification of cardiovascular risk in agreement with the new concept of precision medicine. © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. - Some of the metrics are blocked by yourconsent settings
Publication Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper(2022) ;Koller, Akos (7102499922) ;Laughlin, M. Harold (55663782800) ;Cenko, Edina (55651505300) ;De Wit, Cor (7005808759) ;Tóth, Kálmán (7202014152) ;Bugiardini, Raffaele (26541113500) ;Trifunovits, Danijela (57438313800) ;Vavlukis, Marija (14038383200) ;Manfrini, Olivia (6505860414) ;Lelbach, Adam (8652522900) ;Dornyei, Gabriella (6701614133) ;Padro, Teresa (6701424923) ;Badimon, Lina (7102141956) ;Tousoulis, Dimitris (35399054300) ;Gielen, Stephan (7005725390)Duncker, Dirk J (7005277014)Regular aerobic exercise (RAEX) elicits several positive adaptations in all organs and tissues of the body, culminating in improved health and well-being. Indeed, in over half a century, many studies have shown the benefit of RAEX on cardiovascular outcome in terms of morbidity and mortality. RAEX elicits a wide range of functional and structural adaptations in the heart and its coronary circulation, all of which are to maintain optimal myocardial oxygen and nutritional supply during increased demand. Although there is no evidence suggesting that oxidative metabolism is limited by coronary blood flow (CBF) rate in the normal heart even during maximal exercise, increased CBF and capillary exchange capacities have been reported. Adaptations of coronary macro- and microvessels include outward remodelling of epicardial coronary arteries, increased coronary arteriolar size and density, and increased capillary surface area. In addition, there are adjustments in the neural and endothelial regulation of coronary macrovascular tone. Similarly, there are several adaptations at the level of microcirculation, including enhanced (such as nitric oxide mediated) smooth muscle-dependent pressure-induced myogenic constriction and upregulated endothelium-dependent/shear-stress-induced dilation, increasing the range of diameter change. Alterations in the signalling interaction between coronary vessels and cardiac metabolism have also been described. At the molecular and cellular level, ion channels are key players in the local coronary vascular adaptations to RAEX, with enhanced activation of influx of Ca2+ contributing to the increased myogenic tone (via voltage-gated Ca2+ channels) as well as the enhanced endothelium-dependent dilation (via TRPV4 channels). Finally, RAEX elicits a number of beneficial effects on several haemorheological variables that may further improve CBF and myocardial oxygen delivery and nutrient exchange in the microcirculation by stabilizing and extending the range and further optimizing the regulation of myocardial blood flow during exercise. These adaptations also act to prevent and/or delay the development of coronary and cardiac diseases. © 2021 Published on behalf of the European Society of Cardiology. All rights reserved.